Speaker illustration

Doctor Takeshi Horio

Ishikiriseiki Hospital, Higashi-Osaka (Japan)

Combination therapy with renin-angiotensin system inhibitors and statins is associated with reduced incidence of new-onset atrial fibrillation in hypertensive patients

Event: ESC Congress 2018

Topic: Target Organ Damage/Left Ventricular Hypertrophy

Session: Hypertension and Atrial Fibrillation

Thumbnail

Long-term effect of statin therapy on annual change in renal function in hypertensive patients

Event: ESC Congress 2017

Topic: Treatment of hypertension

Session: Best Posters in hypertension - Understanding and managing

Thumbnail

Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis

Event: ESC Congress 2016

Topic: Haemodynamics, heart and hypertension

Session: Target organ damage in hypertension

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb